Medical information siteNo online sale or prescription. The peptides presented are for supervised, experimental use in consultation and do not replace medical advice.
✦ Regenerative Medicine+212 662 100 418
← Catalogue

TB-500

mobility & recovery protocol
Repair & performance · Recovery & tissue

Thymosin β4 fragment: mobility and recovery.

iThe essentials in 10 seconds

  • Active fragment of Thymosin β4, a repair protein present in the body
  • Promotes mobility, tissue flexibility and recovery
  • Subcutaneous injection, in a course of a few weeks
  • Complement to BPC-157 for tendon-muscle repair

IWhat is TB-500?

TB-500The regenerator

TB-500 is a fragment of Thymosin β4, a protein involved in tissue repair. It promotes cell migration to injured areas, the formation of new vessels and tissue flexibility. It is used for recovery and mobility (tendons, muscles, joints).

Peptide off-label, use reserved for a supervised medical setting. Limited human data: benefits are mainly based on practice and preclinical models.

An innovative approach, an experimental use

The molecules presented on this site are innovative and fall under experimental use. Human data remain limited: a studied mechanism or a preclinical observation is not sufficient to demonstrate a benefit. The regulatory status in Morocco is not established for most of these peptides. Any use is decided within the framework of a medical consultation, with follow-up — never alone, never without an assessment.

IIThe benefits

◆MobilityMore flexible tissues

Improves tissue elasticity and joint mobility.

◆RecoveryReturn to sport

Supports muscle and tendon repair after exertion and shortens recovery.

◆Local circulationNew vessels

Promotes vessel formation (angiogenesis) in areas under repair.

◆InflammationSoothed tissue

Reduces inflammation and stiffness in injured areas.

◆Cellular repairCell migration

Attracts repair cells to the injury site.

◆In combinationWith BPC-157

Combines with BPC-157 for complete repair coverage.

IIIRecommendations & how to use

How to useDosage · route · storage
Reconstitution: vial reconstituted with bacteriostatic water (dilution provided in consultation)

Route: subcutaneous injection (abdomen or thigh) · Frequency: injections spaced out during the week, in a course · Storage: refrigerated (2–8 °C).
To be combined with rehabilitation and rest when indicated.

Prices on request
DosagePrice
5 mgProvided on request
10 mgProvided on request

Prices are not published online: they are provided on request, during a consultation or by telephone.

Supplied as a vial with bacteriostatic water and syringes — reconstituted during the consultation.
Supplied as a vial with bacteriostatic water and syringes — reconstituted during the consultation.

IVThe two protocols

◆Recovery protocolInjury · stiffness · inflammation

Goal: support tissue repair and reduce stiffness after an injury.

Dose: depending on the form, over 4 to 6 weeks
Frequency: injections spaced out during the week
Reassessment at the end of the course

Monitoring: pain, mobility, exercise capacity.

◆Flexibility & sport protocolPrevention · performance

Goal: maintain flexibility and prevent injuries in athletes.

Short course around periods of intensity
Spaced injections, adjusted to the load
Break between courses

Combine with: warm-up, stretching, protein, sleep.

VProtocol rules

Good habits
  • Rehabilitation and rest when indicated
  • Hydration and protein
  • Regular sleep
  • Note pain and mobility
  • Store vials in the refrigerator
To avoid / precautions
  • No self-injection without medical training
  • Do not force a healing area
  • Do not chain courses without a break
  • Never mix peptides in the same vial
  • Progressive cancer: contraindication

VIYour journey in 3 steps

Step 1 · Consultation
Assessment & training

Evaluation, contraindications, injection training, protocol provided.

Step 2 · Course
Injections & monitoring

Spaced injections, monitoring of mobility and recovery.

Step 3 · End of course
Reassessment

Assessment, decision on what comes next (break or new course).

VIISide effects & level of evidence

Level of evidencePreclinicalPreclinical data (in vitro / animal); no published controlled trial in humans.
Reported adverse effects
  • Injection-site reaction
  • Headache
  • Fatigue
  • Dizziness, nausea
Contraindications & precautions
  • Active cancer or cancer history
  • Pregnancy, breastfeeding
  • Children and adolescents
  • Hypersensitivity

Non-exhaustive list based on the available literature and known class effects; it replaces neither a product label nor an individual medical assessment.

VIIIPublications & references